Morgan Stanley cuts target 30% to $213 on AI funding fears while Guggenheim holds $400 target. Wall Street divided on cloud ...

Voisin Consulting Life Sciences (VCLS), a well-established contract research organization (CRO) with a focus on unmet medical need and rare drug clinical trials, has chosen Oracle Argus to ...

U.S. joint venture would help the company diversify and give it its very first "foray into a consumer business," according to ...

Oracle patches roughly 230 unique CVEs across more than 30 products with its first Critical Patch Update (CPU) released in ...

Oracle recognized the AI land grab accelerating in real time: a market rocketing from $80–100 billion today to $350–650 ...

Oracle (ORCL) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Appetite for loans tied to Oracle's data center partnership with OpenAI has diminished, reflecting concerns over credit risk and AI investment scale.

Michael Burry owns put options on ORCL and shorted shares, criticizing cloud expansion strategy and $95 billion debt load.

Oracle has ridden the AI wave through aggressive data-center expansion and a backlog that reached $523 billion in FQ2. That ...

Oracle faces continued downside risk as AI deal optimism fades and market sentiment shifts. Click here to read an analysis of ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90.0 to $300.0 for Oracle over the recent three months. Examining the volume ...

Fears over Oracle’s AI debt load and OpenAI concentration are overblown — and they mask a massive long-term opportunity, ...